Who qualifies for Rybelsus?
Rybelsus · semaglutide (oral) · by Novo Nordisk
Reviewed by the WeighedHealth Editorial Team against primary clinical sources — FDA labeling, peer-reviewed trials, and specialty-society guidelines.
Content current as of July 2026; updated when guidance or availability changes.
FDA indication: type 2 diabetes glycemic control. Off-label weight-loss prescribing occurs. Same thyroid C-cell contraindication as the rest of the class.
More on Rybelsus
- How much does Rybelsus cost?
- Rybelsus side effects
- Rybelsus dosing and titration schedule
- How does Rybelsus work?
- Rybelsus drug interactions
- Rybelsus and pregnancy: safety, planning, breastfeeding
- Rybelsus and alcohol: what to know
- Rybelsus missed dose: what to do
- Rybelsus savings: coupons, manufacturer programs, lower-cost options
- ← Full Rybelsus overview
Frequently asked
Am I eligible for Rybelsus?+
FDA indication: type 2 diabetes glycemic control. Off-label weight-loss prescribing occurs. Same thyroid C-cell contraindication as the rest of the class.
Who should not take Rybelsus?+
Anyone with the documented contraindications listed above. Always disclose full medical history, current medications, and family cancer history to the prescribing clinician.